KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation

Nat Clin Pract Cardiovasc Med. 2007 Feb;4(2):110-6. doi: 10.1038/ncpcardio0792.

Abstract

Background: A 53-year-old female presented with a 10-year history of paroxysmal atrial fibrillation (AF), precipitated by activity and refractory to medical therapy. In the absence of traditional risk factors for disease, a genetic defect in electrical homeostasis underlying stress-induced AF was explored.

Investigations: Echocardiography, cardiac perfusion stress imaging, invasive electrophysiology with isoproterenol provocation, genomic DNA sequencing of K(ATP) channel genes, exclusion of mutation in 2,000 individuals free of AF, reconstitution of channel defect with molecular phenotyping, and verification of pathogenic link in targeted knockout.

Diagnosis: K(ATP) channelopathy caused by missense mutation (Thr1547Ile) of the ABCC9 gene conferring predisposition to adrenergic AF originating from the vein of Marshall.

Management: Disruption of arrhythmogenic gene-environment substrate at the vein of Marshall by radiofrequency ablation.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP-Binding Cassette Transporters / genetics
  • Atrial Fibrillation / diagnostic imaging
  • Atrial Fibrillation / genetics*
  • Atrial Fibrillation / surgery*
  • Catheter Ablation / methods*
  • Channelopathies / genetics*
  • Channelopathies / therapy
  • Chronic Disease
  • Coronary Vessels / physiopathology
  • Echocardiography, Doppler
  • Female
  • Humans
  • Kv1.5 Potassium Channel / genetics*
  • Middle Aged
  • Mutation, Missense
  • Risk Assessment
  • Tachycardia, Paroxysmal / diagnostic imaging
  • Tachycardia, Paroxysmal / genetics
  • Tachycardia, Paroxysmal / surgery
  • Treatment Outcome

Substances

  • ATP-Binding Cassette Transporters
  • Kv1.5 Potassium Channel